I've been looking at a few industry reports on the future of biopharma as part of a course I'm on with INSEAD Business School on Business Strategy and Financial Performance. I thought I'd share some of my ramblings on Biopharma Futures. Expectations are high Pharmaceutical
companies are operating...
Source: deanjenkins.me
Biopharma in 2020 has shown what it can achieve when it works at its best. How can the industry build on this renewed sense of purpose in the years ahead? McKinsey biopharma 2020 3 Overarching trends Operating under a spotlight - expectation of innovationNavigating protracted economic uncertainty -...
Source: mckinsey.com
Four core areas of medical affairs combine to maximize patient experiences and outcomes.
Source: mckinsey.com
Not the last pandemic: Investing now to reimagine public-health systems: Targeted investments can accelerate the global response to COVID-19 and strengthen public-health systems to prevent pandemics in the future.
Source: mckinsey.com
Five management strategies for getting the most from artificial intelligence (AI). "To find out more about what contributes to successful AI adoption, we helped lead a survey by the McKinsey Global Institute of 3,000 C-level executives across 10 countries and 14 sectors. From that research, we identified...
Source: mit.edu
The rise of the robots
Excellent read but of a gloomy dystopian future where robots and software take over manual tasks (as they already have done) and also skilled labour displacing even highly skilled jobs in time. Healthcare might survive a little longer but physicians assistants empowered by...
Source: amazon.co.uk